Jim Plante, Founder And CEO Of Pathway Genomics Corporation, Appointed By US Secretary Of Commerce And US Trade Secretary To Industry Trade Advisory Committee (ITAC)

Published: May 14, 2015

SAN DIEGO & WASHINGTON--(BUSINESS WIRE)--Pathway Genomics Corporation, a data-driven global healthcare company and global clinical laboratory, today announced that Founder and CEO Jim Plante has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3).

Help employers find you! Check out all the jobs and post your resume.

Back to news